Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ
Key stats Fiscal year 2025
Income statement
- Revenue
- 2,000,000
- Net income
- 75,324
- Gross profit
- 13,000
- Operating income
- -15,088,000
- Earnings per share
- 1.50
- Net margin
- 3.77
Balance sheet
- Total assets
- 230,864,000
- Shareholders' equity
- 199,744,000
- Cash and equivalents
- 45,947,000
- Current ratio
- 6.98
Cash flow and ratios
- Operating cash flow
- -9,145,000
- Free cash flow
- -9,154,000
- Return on equity
- 0.04
Revenue and net income
Fiscal year end: · Source: SEC EDGAR
Oramed Pharmaceuticals Inc. trades on NASDAQ under the ticker symbol ORMP. This page brings together its price chart, company profile, key financial figures and technical indicators.